Press release Archives - Artios Pharma

Artios Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

19 December 2024 | Press release

Article-3-400×400

Artios Pharma Bolsters Board of Directors with Appointment of Chris Liu, PhD

9 April 2024 | Press release

Article-1-1-400×400

Artios Pharma Strengthens Financial Leadership with Appointment of Christine Silverstein as Chief Financial Officer

7 February 2024 | Press release

Artios Presents Positive Initial Phase 1/1b Clinical Monotherapy Data for ATR Inhibitor ART0380 in Advanced Solid Tumors at the European Society of Medical Oncology Congress 2023

23 October 2023 | Press release

featured-lg

Artios to Present Initial Phase 1 Clinical Monotherapy Data for ATR Inhibitor ART0380 in Advanced Solid Tumors at the European Society of Medical Oncology Congress 2023

5 October 2023 | Press release

Article-2-400×400

IUCT-Oncopole & Artios join forces to overcome resistance to therapies for familial breast cancer

13 April 2023 | Press release

Capture

Artios Announces Initiation of Phase 2 Randomized Trial for ATR Inhibitor ART0380 plus Gemcitabine in Patients with Platinum Resistant Ovarian Cancer

9 February 2023 | Press release

Article-1-1-400×400

Artios initiates Phase 2 study of Polθ Inhibitor ART4215 in Combination with PARP Inhibitor Talazoparib in BRCA Deficient Breast Cancer

10 August 2022 | Press release

Artios Appoints Samantha Truex to Board of Directors

23 June 2022 | Press release

For press release

Artios Announces ATR Inhibitor, ART0380, Development On Track and Progressing Into Phase 1b Evaluation

5 April 2022 | Press release

shutterstock_1184899237 4 MB

1 2 3 4 Next »

© Artios Pharma 2024 | Website by Granite 5

Terms & conditions | Privacy policy | Site map